Cash operating expenses for Q1 2025 were $2.9 million, down from $4.2 million in Q1 2024. Excluding non-cash stock-based compensation expense, these amounts were $2.7 million for Q1 2025 compared to ...
SAN MATEO, Calif., March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results